FDA Inspection 1106639 — Biotest Pharmaceuticals Corporation
The FDA completed an inspection of Biotest Pharmaceuticals Corporation on September 19, 2019 in Jacksonville, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 19, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Jacksonville, NC (United States)